Drugs / Josamycin
last change Sep 2011 re-read 3 minutes ago

Josamycin

Small molecule

Investigated by
Assistance Publique - Hôpitaux de Paris · Bayer

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00718705 Jul 2008 → Sep 2011 — Assistance Publique - Hôpitaux de Paris Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Josamycin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00718705 ↗
Known as EN-141 ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Iosalide ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Jomybel ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Josamicina ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Josamina ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Josamycine ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Kitasamycin a3 ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Leucomycin a3 ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Known as Turimycin a5 ChEMBL registry synonym — accepted as the source's own label CHEMBL224436 ↗
Modality Small molecule — CHEMBL224436 ↗
Route Oral “josamycin with posology of 2 grams per day by oral way during 10 days” NCT00718705 ↗